BCAN's Patient Handbook - Bladder Cancer Basics for the Newly Diagnosed



Donate Now to Support the Bladder Cancer Advocacy Network



Join The Online Bladder Cancer Support Community



The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012.
  • We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN.
  • No federal or Marine Corps endorsement is implied.
  • If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.
  • abmessing.jpg
    Edward M. Messing, M.D., FACS
    Professor of Urology
    University of Rochester Medical Center
    Dr. Messing received his M.D. degree from New York University in 1972, did his surgery training at NYU-Bellevue Hospital in New York 1972-1974, and his Urology Residency at Stanford University 1974-1978.  After 2 years on the faculty at Tulane University, he completed a fellowship in Urologic Oncology at UCLA in 1982.  He was on the faculty of the Division of Urology at the University of Wisconsin from 1982-1995, being Director of their Urologic Oncology Program for the last 10 years.

    He assumed his current position as Chairman of the Department of Urology at the University of Rochester School of Medicine and Dentistry in September 1995 and also currently serves as Deputy Director of the James P. Wilmot Cancer Center.  Dr. Messing has served as an Examiner on the American Board of Urology and AUA Joint Examining Committee, and serves on the American Urological Association Guidelines Panel on the Evaluation of Hematuria.  Dr. Messing also holds a leadership position on the Local Renal Cancer Subcommittee of the GU Committee of the Southwest Oncology Group and was formerly co-chair of the GU Committee of the Eastern Cooperative Oncology Group. Dr. Messing is a renowned expert in the diagnosis and treatment of cancers of the prostate, bladder and kidney, carries on extensive research in the basic biology of these cancers, and has been the principal investigator on numerous clinical studies for the detection, prevention and treatment of them.
    Click here for information.